SHORT MINI-FUTURE - AMGEN | Delayed Deutsche Boerse AG 05:30:11 02/07/2024 pm IST | ||
| 6.72 EUR | -0.30% |
|
| Current month | +2.90% | ||
| 1 month | -6.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 02/24/02 | 6.72 | -0.30% |
| 01/24/01 | 6.74 | +2.90% |
| 28/24/28 | 6.55 | -0.61% |
| 27/24/27 | 6.59 | +1.70% |
| 26/24/26 | 6.48 | +9.64% |
Delayed Quote Deutsche Boerse AG
Last update July 02, 2024 at 05:30 pm IST
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM9NYH |
| ISIN | DE000VM9NYH7 |
| Date issued | 02/02/2024 |
| Strike | 383 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.81 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.44 € |
|---|---|
| Lowest since issue | 5.38 € |
| Spread | 0.08 € |
| Spread % | 1.18% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
311
USD
Average target price
316.4
USD
Spread / Average Target
+1.75%
- Stock Market
- Certificates
- Certificat
